An examination of the mechanisms driving the therapeutic effects of an AAV expressing a soluble variant of VEGF receptor-1
Seo Yun Moon(Catholic University of Korea), Steven Hyun Seung Lee(Korea Drug Research Association)
Cited by 1
Related Papers
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
|BMC Cancer|2021|27
Intravitreally Administered Soluble VEGF Receptor-1 Variant Tested as a Potential Gene Therapeutic for Diabetic Retinopathy
|Advances in Cell and Gene Therapy|2022|3